Bicalutamide + Midazolam Interaction
Unknowninteraction on record
Description
Clinical studies have shown that with coadministration of bicalutamide, mean midazolam (a CYP 3A4 substrate) levels may be increased 1.5-fold (for C max ) and 1.9-fold (for AUC).
Source: FDA drug label - bicalutamide